Ledger.Open graph →
SEC Form D · filed June 3, 2022

Kera Therapeutics, Inc

Offering
$1.9M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jason Werner · Medfield, MAExec · DirectorReza Dana · Medfield, MADirectorJiagang Zhao · Medfield, MADirectorDavid Neafus · Medfield, MAExecGeorge Mulhern · Boise, IDExecRick Farnell · Boise, IDDirectorBrad Osborne · Brentwood, TNDirectorNick Efstratis · Boise, IDExec · DirectorRobert J. Short · Polson, MTDirectorChris Popp · New York, NYExecMike Tobin · New York, NYDirectorJean-Bastien Auger · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗